Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability of magnetoencephalography beta desynchronization for language lateralization in a subsequent memory effect paradigm.

Clinical neurophysiology practice·2026
Same author

Peristomal Pyoderma Gangrenosum Related to Systemic Lupus Erythematosus: A Case Study.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society·2026
Same author

Remote Patient Education for People Living with an Ostomy: An Italian Expert Consensus Using a Modified Delphi Method.

Nursing reports (Pavia, Italy)·2026
Same author

Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.

Nature communications·2026
Same author

Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival.

Neuro-oncology·2026
Same author

Psychometric Validation of the PHQ-9 in Ostomy Patients and Their Informal Caregivers: Evidence From A European Multicenter Study.

Nursing open·2026

Related Experiment Video

Updated: Jun 24, 2025

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

9.7K

Mapping myeloid cell function: Spatial diversity in tumor and neuronal microenvironment.

Giulia Villa1, Daniel Delev2, Dieter Henrik Heiland3

  • 1Department of Translational Neurosurgery, Alexander-Friedrich-Universität Erlangen-Nürnberg, Erlangen, Germany.

Cancer Cell
|June 11, 2024
PubMed
Summary

Researchers found that TREM2 has a dual role in myeloid cells within glioblastoma. It promotes inflammation at the tumor-neural interface but suppresses it in the tumor core, offering new immunotherapy strategies.

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.1K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.6K

Related Experiment Videos

Last Updated: Jun 24, 2025

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

9.7K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.1K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.6K

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Biology

Background:

  • Glioblastoma is an aggressive brain tumor with a complex tumor microenvironment.
  • Myeloid cells play a critical role in glioblastoma progression and immune evasion.
  • TREM2 (triggering receptor expressed on myeloid cells 2) is a key receptor on myeloid cells, but its precise role in glioblastoma is not fully understood.

Purpose of the Study:

  • To investigate the specific functions of TREM2 in different regions of the glioblastoma microenvironment.
  • To elucidate the impact of TREM2 on glioblastoma-associated myeloid cells and their inflammatory functions.
  • To explore the potential of targeting TREM2 for novel neuro-oncological immunotherapies.

Main Methods:

  • Single-cell RNA sequencing to analyze myeloid cell populations.
  • Spatial transcriptomics to map gene expression within the tumor.
  • In vivo and in vitro functional assays to assess TREM2 activity.

Main Results:

  • TREM2 expression and function vary significantly between the tumor-neural interface and the tumor core.
  • At the tumor-neural interface, TREM2 promotes inflammatory responses in myeloid cells.
  • Within the tumor core, TREM2 exhibits immunosuppressive functions, influenced by the local microenvironment.

Conclusions:

  • TREM2 plays a context-dependent, dual role in glioblastoma myeloid cells.
  • Understanding TREM2's regional functions is crucial for developing effective glioblastoma immunotherapies.
  • Targeting TREM2 offers a promising avenue for future neuro-oncological treatment strategies.